Developers from the IO Division of Nexon Games took to the stage at "AX 2026" on the 5th of this month, participating in a panel discussion that offered the industry its clearest — if still frustratingly incomplete — glimpse yet of an internally coded project known as "Project RX." The team shared elements of the game's design philosophy and technical direction, but steadfastly refused to reveal its official title, a calculated omission that has set the gaming industry buzzing.
AX 2026 is a conference-style event focused on the intersection of game development and artificial intelligence, drawing studios and developers from across the industry. This year, particular attention fell on panel sessions dedicated to next-generation intellectual property (IP) development. Nexon Games' IO Division chose this prominent platform to publicly reaffirm the existence of Project RX — a meaningful signal in itself.
Nexon Games is a subsidiary of Nexon, one of South Korea's largest gaming companies, and is the studio behind hit titles such as "Blue Archive." Its IO Division — the acronym stands for In-house Organisation — operates as a semi-autonomous unit within the company, tasked with developing new IP that departs from Nexon Games' established genre identity. Industry observers have long believed the division is targeting AAA-grade content in the action or open-world category.
At the AX 2026 session, developers are understood to have touched on the core design principles and technical framework underpinning Project RX. Yet by withholding the official title, they implicitly signalled that neither the game's development nor its marketing strategy has reached its final stage. Convention in the industry dictates that studios announce official titles in tandem with trailers and platform release plans — meaning silence on the name suggests those pieces are not yet in place.
Industry analysts interpret the approach as a deliberate reveal strategy. "Locking in an IP name before a developer has a polished build carries real brand risk," said one games analyst. "The fact that Nexon Games participated in a public session while withholding the title strongly suggests a phased disclosure strategy tied to the release schedule."
There is ample precedent for this playbook. Square Enix in Japan has successfully incubated projects through dedicated internal teams, then deployed rapid global marketing campaigns once official titles were announced. In South Korea, Krafton did something similar with "Project Redgate" and other code-named titles, using the pre-announcement period to cultivate community interest before a formal launch.
The broader market context lends further urgency to the project. The global gaming industry is accelerating its shift away from mobile towards cross-platform titles spanning consoles and PC. According to Newzoo, a market research firm, PC and console gaming accounted for more than 50% of the global games market in 2025 — roughly five percentage points higher than in 2021. The IO Division appears to be developing a title precisely calibrated to capitalise on this trend.
Investors are paying close attention. As Nexon's principal development subsidiary, Nexon Games' new IP announcements have a direct bearing on the parent company's share price and portfolio diversification. Should Project RX prove to offer genuine cross-platform breadth beyond Nexon's predominantly mobile lineup, it could become a pivotal weapon in the group's drive to expand internationally.
The key questions now are when the official title will be announced and what the platform strategy will look like. Industry insiders expect Nexon Games to lift the veil on Project RX around the time of a major gaming expo in the second half of 2026 — either the Tokyo Game Show or South Korea's G-STAR. The prevailing view is that the AX 2026 session served as an opening gambit: a carefully staged move to establish the project's presence in the market before the main reveal. How quickly and smoothly that information is disclosed will be the first real test of whether Project RX can live up to its considerable early intrigue.